Dianthus Therapeutics Inc <DNTH.O>: Baird assumes coverage with outperform rating; target price $132
DNTH•Related News
Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech
XLV•
ExxonMobil <XOM.N>: Jefferies raises target price to $200 from $184
XOM•
Borr Drilling director’s close associate buys USD 2.19 million stake
BORR•
Gold edges higher on softer dollar as rate-hike expectations ease
GLD•
Japan Q2 growth misses forecasts on weaker spending, investment
EWJ•